Synthesis and DNA binding studies of novel triazine-isatin hybrids: experimental and computational insights.

DNA binding is a crucial determinant in developing novel anticancer agents, as it plays a key role in the mechanism of action for many chemotherapeutic drugs. In this study, a series of novel -triazine-isatin hybrids (7a-f) was synthesized, and their binding interactions with salmon sperm DNA (SS-DNA) were investigated under physiological conditions (pH 7.4) using UV-vis absorption spectroscopy. The experimental findings demonstrated strong DNA-binding affinity through absorption and intensity shifts groove-binding modes with SS-DNA. The binding constants ( ) of synthesized hybrids with SS-DNA calculated from the Benesi-Hildebrand plot, ranged from 10 to 10 M, with compound 7f exhibiting the highest binding constant (9.51 × 10 M) at 298 K, surpassing the reference cabozantinib. The Gibbs free energy change in the binding interaction of 7f, was found to be Δ = -34.1 kJ mol indicating a spontaneous binding process. The molecular docking results supported experimental findings with a docking score of -10.3 kcal mol for 7f, highlighting hydrophobic and hydrogen bonding interactions within the AT-rich region of DNA grooves. In addition, DFT and studies provided insights into the charge density of structures and drug-likeness, hence the -triazine-isatin hybrid core holds promise as a potential therapeutic agent.